NeuroKaire
Move beyond antidepressant trial-and-error.
$10M ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJan 24, 2022 (4 years old)
About NeuroKaire
NeuroKaire biological testing reveals how your neurons respond to depression medication before treatment.
Funding rounds
- Round · $10MSource: fundraisingfox.com
- Website created
Founders and team
TC
Talia Cohen Solal CEO & Co-Foundersource: neurokaire.comDL
Daphna Laifenfeld CSO & Co-Foundersource: neurokaire.com
Investors
EEuropean Innovation Council Fund
GGreyBird Ventures
HHoward Morgan
JJumpspeed Ventures
MMeron Capital
MMichael Zeisser
SSapir Venture Partners
Companies like NeuroKaire
MMarketDial$6M Series A · Oct 2025
AAlphabiome$8M Seed · May 2025EElkedonia$13M Seed · Jul 2025
OOutro Health$7M Seed · Oct 2026
FFlow Neuroscience
IInner CosmosSeed
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neurokaire (get a free API key).